ArticlePharmaceutical medicine2021

Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities.

Daniella Balduino Victorino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.